药物开发
2019年冠状病毒病(COVID-19)
生物
计算生物学
药品
合成生物学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
大流行
药物发现
计算机科学
病毒学
生物信息学
医学
药理学
传染病(医学专业)
疾病
病理
爆发
作者
Andrew Hill,Jane M. True,Charles H. Jones
标识
DOI:10.1016/j.tibtech.2024.01.008
摘要
Abstract
The COVID-19 pandemic has thrust RNA as a platform for drug development into the spotlight. However, identifying promising drug candidates is challenging. With advances in synthetic biology and artificial intelligence (AI) models, we can overcome this hurdle, transforming drug development and ushering in a new era in the pharmaceutical industry.
科研通智能强力驱动
Strongly Powered by AbleSci AI